Hum zzan growth hormone I GRUNT, CRIGLER, SLONE, SOELDNER NIATERIALS AND METHODS
A total of 17 children were studied. The clinical characteristics are summarized in Table 1 . Seven (Group I, ages 9-15 years-heights from the 25th to the 75th percentile) were normal; five (Group II, ages 7-14 years-heights from the 1st to the 3rd percentile) were "normal" but considered genetically short because of a positive family history of short stature, a normal growth rate over the previous years and a lack of demonstrable endocrinopathies; and five (Group III, ages 9-11 yearsheights significantly below the 1st percentile) had slow growth rates and deficiencies of one or more anterior pituitary hormones. Each subject had an evaluation of his CNS-pituitary function that included a protein-bound iodine, cholesterol, thyroidal I" differences between groups and within groups before and after HGH ( Table 2 ). Mean fasting IRI concentrations before and after HGH administration in the children with pituitary deficiencies (Group III) were significantly lower (P < 0.01) than those of the normal children (Group I) or children with genetic short stature (Group II). The mean fasting IRI concentration of Group II was significantly less (P < 0.02) than that of Group I without HGH. The same type of difference in serum IRI concentrations between Group I and II is apparent after HGH although the number of subjects and the variability of the IRI values were such that the differences observed were not significant. A single intramuscular injection of 2 mg. of HGH appears to have no effect on serum IRI concentrations obtained four hours later in any of the groups. The blood sugar concentrations of both Group I and Group II prior to HGH were significantly greater than the mean BS concentration of Group III (P < 0.01) but not significantly different from each other ( Table 2) . Following the single IM injection of HGH there were no significant differences among the three groups, since the mean BS concentration of the children in Group III had increased. The number of BS determinations on children in Group III after HGH, however, were not sufficient to establish a significant effect of HGH on BS concentrations in this group In addition, long-term (5-10 days, 10 mg/d) HGH administration has been accompanied by deterioration in carbohydrate tolerance, and elevations in FBS and serum IRI. Similar observations of augmentation of growth hormone after insulin secretion in dogs have been reported.'" However, Kipnis and Stein" found no significant change in either blood glucose or serum IRI during a five hour intravenous infusion of HGH to normal adults or to adults with hypopituitarism, although a significant rise of plasma FFA was seen in both groups. The responses of the children in this study given one intramuscular injection of 2 mg. of HGH were similar to those reported by the latter group.
Since changes in serum IRI concentrations have not been observed after single IM injections or five hour intravenous infusions, the effect of HGH on IRI secretion in zvivo must not be directly on pancreatic islet cell tissue.
The children with genetic short stature who were studied come from families in which there were many other short individuals. Their heights were within two standard deviations of the average for age and they were growing at a normal rate. In addition, they had no clinical or laboratory evidence of endocrine dysfunction. For these reasons, the observed significant differences in fasting serum IRI and FFA concentrations between this group and the children with normal stature were unexpected. These differences cannot be completely explained, since sufficient data on a normal group of children of the same age and degree of development are not available. However, previously reported studies1" from our laboratories have shown that children from 3 to 9 years of age have fasting serum IRI concentrations significantly lower than infants up to 2 years, adolescents 10-16 years, and adults. Since two of the children in Group II were 7 years of age, it seems possible that the lowered mean IRI concentration in Group II may be attributed, in part, to the fact that the children were younger than those in Group I. The fact that the changes in IRI and FFA are in the same direction as those found in the children with hypopituitarism, although less marked, raises the possibility that the subjects included in Group II may have an alteration in HGH metabolism (synthesis, release, tissue response, etc.). The likelihood that there is a genetic determinant for this possible metabolic alteration warrants additional study. SUMMARY Serum immunoreactive insulin (IRI), fasting blood sugars (FBS), and free fatty acids (FFA) were obtained on two days after fast periods of 8 and 12 hours from seven normal children (Group I, ages 9-15 yearsheights, above the 25th percentile), five genetically short children (Group II, ages 7-14 years-heights between the 1st and 3rd percentile) and five children with idiopathic hypopituitarism (Group III, ages 9-11 yearsheights significantly below the 1st percentile). On the second day, 4 to 7 days after the first study, two milligrams of human growth hormone (HGH) were administered intramuscularly after obtaining the 8 hour blood sample. Within each group mean serum IRI values after 8 and 12 hour periods of fast were not significantly different. Mean IRI values in the children in Group I were 9.2 microunits/ml., in Group II, 5.9 microunits/ml., and in Group III, 2.3 microunits/mil., the IRI concentrations in the hypopituitary children being significantly lower (P < 0.01) than in the other two groups. Four hours after HGH, mean IRI concentrations wvere not significantly increased in any of the groups. Mlean FBS values at 8 hours in the hypopituitary group were lower than the other two groups b)ut were not significantly increased in any group after HGH. Mean 8 and 12 hour fasting FFA in the hypopituitary subjects and mean 12 hour fasting FFA in the genetically short subjects were significantly greater than those in the normal subjects. All three groups showed the expected increases (two to threefold) in FFA after HGH.
These results show that children with hypopituitarism have lower fasting concentrations of IRI and blood sugar but higher and more variable concentrations of FFA. A single IM injection of HGH, capable of increasing plasma FFA in normal as well as hypopituitary subjects, did not increase serum IRI or blood sugar concentrations significantly in any of the subjects. An unexpected finding was that mean fasting IRI levels were significantly lower in genetically short children as compared with controls.
